Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Is it correct for a woman with multiple sclerosis to forgo medication because she may become pregnant?
Coenzyme Q(10) and idebenone in the therapy of respiratory chain diseases: rationale and comparative benefits.
Microglia, physiology and behavior: A brief commentary.
VZV encephalitis that developed in an immunized patient during fingolimod therapy.
[Relevance of Magnet Resonance Tomography in the Diagnosis and Assessment of Course of Disease in Patients with Multiple Sclerosis].
Atypical presentation of Charcot-Marie-Tooth disease 1A: A case report.
[Epidemiology of multiple sclerosis].
Progressive cerebral atrophy in neuromyelitis optica.
Hypothesis: Fingolimod explores new horizons in treatment of lymphoma.
[The application of high-frequency and iTBS transcranial magnetic stimulation for the treatment of spasticity in the patients presenting with secondary progressive multiple sclerosis].
Brain cytokines and disease.
Vaccines in Multiple Sclerosis.
Relationship between symptom change, relapse activity and disability progression in multiple sclerosis.
Preclinical Models of Multiple Sclerosis: Advantages and Limitations towards Better Therapies.
Activation of oligodendroglial Stat3 is required for efficient remyelination.
Progression, Symptoms and Psychosocial Concerns among Those Severely Affected by Multiple Sclerosis: A Mixed-Methods Cross-Sectional Study of Black Caribbean and White British People.
Treatment Costs and Patterns In Patients With Multiple Sclerosis Treated With Prolonged-Release Fampridine In Germany.
Vitamin D-related gene expression profiles in immune cells of patients with relapsing remitting multiple sclerosis.
EAE: imperfect but useful models of multiple sclerosis.
MSRV envelope protein is a potent, endogenous and pathogenic agonist of human toll-like receptor 4: Relevance of GNbAC1 in multiple sclerosis treatment.
[Actual medical care situation and therapeutic needs in multiple sclerosis : Impact of the Pharmaceutical Market Restructuring Act (AMNOG)].
Optic neuritis as a possible phenotype of anti-GQ1b/GT1a antibody syndrome.
A Limited Form of Neuromyelitis Optica With a Lesion of the Fourth Nerve Nucleus.
Leukocyte Gene Expression and Plasma Concentration in Multiple Sclerosis: Alteration of Transforming Growth Factor-βs, Claudin-11, and Matrix Metalloproteinase-2.
Multi-channel registration of fractional anisotropy and T1-weighted images in the presence of atrophy: application to multiple sclerosis.
Pages
« first
‹ previous
…
668
669
670
671
672
673
674
675
676
…
next ›
last »